Category Archives: Cancer

Burzynski Institute: Patient Exploitation in the Name of Research

A cursory glance at the website of the Burzynski Research Institute Inc. turns up nothing unusual. The website showcases smiling patients and its shiny, mirror-windowed building. There’s a contact number for patients to call and a prominent “Donate” button, implying…

Share

Michele Bachmann Endangered Women’s Lives

Teary-eyed mother to Michele Bachmann: Michele, my daughter took the HPV vaccine and spontaneously became mentally retarded. Michele Bachmann to the world: We must stop the use of these dangerous government-mandated vaccines which infringe on our liberties as Americans and…

Share

Will Dendreon’s Slide Force Cancer Vaccines Out of Style?

Back in 2008, biotech companies working on cancer vaccines were not exactly shouting it from the rooftops. In fact, most companies working in the space quietly began branding their drug candidates “immunotherapies” when they met with investors in an attempt…

Share

Unless it’s Affordable, Curing Cancer is Just a Dream

Although they’re the stuff of science, statistics too often lack the power to move us. After all, they’re just numbers. So when companies like Dendreon Corp. and Seattle Genetics Inc. price their cancer treatments at nearly $100,000 or more, we…

Share

Extra! Extra! Leukemia Treatment Purposely Misses Holy Grail!

This week’s report of remissions in three advanced leukemia patients after immunotherapy has generated quite a lot of excitement in the media – which, in turn, has led to some backlash amongst the twitterati and in the blogosphere, noting that…

Share

The Scariest Thing about Dendreon’s Implosion

As a biotech junkie, I’ll admit I was shocked to the core by Dendreon Corp.’s second-quarter admission that prostate cancer vaccine Provenge (Sipuleucel-T) is thus far not succeeding commercially. (See BioWorld’s news bulletin for details.) The most shocking part? Analyst…

Share

A Tale of Two Conferences: ASCO and BIO

The American Society of Clinical Oncology (ASCO) Annual Meeting kicked off the month of June as, arguably, the biggest event in the life sciences milieu, with 30,000-plus attendees and an inconsistent mélange of dispiriting and heartening news and data, while…

Share

The HIV Cure and a Culture of Low Expectations

By Catherine Shaffer, BioWorld Today Contributing Writer   If you do a web search on the term “cancer cure,” you’ll get pages and pages of conspiracy theories, alternative medicine sites, and home-cooked “natural” remedies. Some of them, like baking soda…

Share

LJPC, GNTA Not Dead Yet

It looked Monday as if two of biotech’s long-suffering names might finally be biting the dust. Genta Inc. threw in the towel on beleaguered antisense drug Genasense (oblimersen sodium), after a final analysis of a Phase III melanoma trial –…

Share